GB0822672D0 - Anti-viral protection with viruses containing a defective genome - Google Patents

Anti-viral protection with viruses containing a defective genome

Info

Publication number
GB0822672D0
GB0822672D0 GBGB0822672.2A GB0822672A GB0822672D0 GB 0822672 D0 GB0822672 D0 GB 0822672D0 GB 0822672 A GB0822672 A GB 0822672A GB 0822672 D0 GB0822672 D0 GB 0822672D0
Authority
GB
United Kingdom
Prior art keywords
viruses containing
defective genome
viral protection
viral
genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0822672.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Warwick
Original Assignee
University of Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Warwick filed Critical University of Warwick
Priority to GBGB0822672.2A priority Critical patent/GB0822672D0/en
Publication of GB0822672D0 publication Critical patent/GB0822672D0/en
Priority to AU2009326204A priority patent/AU2009326204B2/en
Priority to DK09774920.4T priority patent/DK2355834T3/da
Priority to PCT/GB2009/051666 priority patent/WO2010067109A1/en
Priority to ES09774920T priority patent/ES2423193T3/es
Priority to PL09774920T priority patent/PL2355834T3/pl
Priority to US13/132,593 priority patent/US8691215B2/en
Priority to EP09774920.4A priority patent/EP2355834B1/en
Priority to CN200980149732.4A priority patent/CN102256611B/zh
Priority to CA2746495A priority patent/CA2746495C/en
Priority to IN2819KON2011 priority patent/IN2011KN02819A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0822672.2A 2008-12-12 2008-12-12 Anti-viral protection with viruses containing a defective genome Pending GB0822672D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0822672.2A GB0822672D0 (en) 2008-12-12 2008-12-12 Anti-viral protection with viruses containing a defective genome
IN2819KON2011 IN2011KN02819A (https=) 2008-12-12 2009-12-08
ES09774920T ES2423193T3 (es) 2008-12-12 2009-12-08 Protección antiviral con virus que contienen segmentos de genoma defectuoso
DK09774920.4T DK2355834T3 (da) 2008-12-12 2009-12-08 Anti-viral beskyttelse med vira omfattende defekte genom-segmenter
PCT/GB2009/051666 WO2010067109A1 (en) 2008-12-12 2009-12-08 Anti-viral protection with viruses containing defective genome segments
AU2009326204A AU2009326204B2 (en) 2008-12-12 2009-12-08 Anti-viral protection with viruses containing defective genome segments
PL09774920T PL2355834T3 (pl) 2008-12-12 2009-12-08 Ochrona przeciwwirusowa z zastosowaniem wirusów zawierających defektywne segmenty genomu
US13/132,593 US8691215B2 (en) 2008-12-12 2009-12-08 Anti-viral protection with viruses containing defective genome segments
EP09774920.4A EP2355834B1 (en) 2008-12-12 2009-12-08 Anti-viral protection with viruses containing defective genome segments
CN200980149732.4A CN102256611B (zh) 2008-12-12 2009-12-08 使用含缺损基因组片段的病毒的抗病毒保护
CA2746495A CA2746495C (en) 2008-12-12 2009-12-08 Anti-viral protection with viruses containing a defective genome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0822672.2A GB0822672D0 (en) 2008-12-12 2008-12-12 Anti-viral protection with viruses containing a defective genome

Publications (1)

Publication Number Publication Date
GB0822672D0 true GB0822672D0 (en) 2009-01-21

Family

ID=40325992

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0822672.2A Pending GB0822672D0 (en) 2008-12-12 2008-12-12 Anti-viral protection with viruses containing a defective genome

Country Status (11)

Country Link
US (1) US8691215B2 (https=)
EP (1) EP2355834B1 (https=)
CN (1) CN102256611B (https=)
AU (1) AU2009326204B2 (https=)
CA (1) CA2746495C (https=)
DK (1) DK2355834T3 (https=)
ES (1) ES2423193T3 (https=)
GB (1) GB0822672D0 (https=)
IN (1) IN2011KN02819A (https=)
PL (1) PL2355834T3 (https=)
WO (1) WO2010067109A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019685B1 (en) 2006-05-24 2014-11-12 The University Of Warwick Defective interfering virus
GB2522615A (en) * 2014-01-16 2015-08-05 Univ Warwick Assay and medicament
WO2019206285A1 (en) * 2018-04-26 2019-10-31 The University Of Hong Kong Nucleic acid molecules and dual-functional peptides having antiviral activity and delivery activity, compositions and methods thereof
GB202209861D0 (en) * 2022-07-05 2022-08-17 Univ Court Univ St Andrews Viral vectors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
JP5147405B2 (ja) 2004-10-06 2013-02-20 メディミューン，エルエルシー 冷蔵温度安定型インフルエンザワクチン組成物
AU2005303817B8 (en) 2004-11-11 2010-09-30 Abbott Biologicals B.V. Defective influenza virus particles
EP2019685B1 (en) 2006-05-24 2014-11-12 The University Of Warwick Defective interfering virus
GB2437799B (en) * 2006-05-24 2008-08-13 Univ Warwick Defective interfering virus

Also Published As

Publication number Publication date
CN102256611A (zh) 2011-11-23
ES2423193T3 (es) 2013-09-18
US8691215B2 (en) 2014-04-08
US20110243896A1 (en) 2011-10-06
CA2746495C (en) 2018-04-17
AU2009326204A1 (en) 2011-06-23
CA2746495A1 (en) 2010-06-17
DK2355834T3 (da) 2013-07-29
EP2355834B1 (en) 2013-05-01
EP2355834A1 (en) 2011-08-17
WO2010067109A1 (en) 2010-06-17
PL2355834T3 (pl) 2014-03-31
IN2011KN02819A (https=) 2015-07-10
AU2009326204B2 (en) 2014-01-09
CN102256611B (zh) 2014-05-21

Similar Documents

Publication Publication Date Title
GB0813916D0 (en) A Protection arrangement
GB0814213D0 (en) A protection arrangement
HUS1500019I1 (hu) Hepatitisz C vírus inhibitorok
EP2252558A4 (en) DAMAGING RESISTANT, CHEMICALLY PREVENTED PROTECTIVE GLASS
IL219516A (en) Hepatitis virus inhibitors c
IL219517A0 (en) Hepatitis c virus inhibitors
IL214775A0 (en) Hepatitis c virus inhibitors
IL214098A0 (en) Hepatitis c virus inhibitors
IL215055A0 (en) Hepatitis c virus inhibitors
IL214939A0 (en) Hepatitis c virus inhibitors
EP2475256A4 (en) HEPATITIS C-VIRUS HEMMER
IL215095A0 (en) Hepatitis c virus inhibitors
EP2512480A4 (en) HEPATITIS C-VIRUS HEMMER
GB0807424D0 (en) Virus
GB0714578D0 (en) Viruses
PL2143397T3 (pl) Szyny nazębne z listwami złącznymi
PL2208664T3 (pl) Zabezpieczenie na kierownicy
GB0822672D0 (en) Anti-viral protection with viruses containing a defective genome
GB0819084D0 (en) ESD protection
EP2371175A4 (en) INCREASED ERROR CORRECTION POWER
GB0912950D0 (en) Virus
GB0720624D0 (en) Viral Modification
PL2019685T3 (pl) Defektywny interferujący wirus
GB0713311D0 (en) Pallet racking shield
GB0901056D0 (en) Virus